The short answer
PI-RADS 5 means clinically significant cancer is highly likely. Two different findings earn it: a lesion of 1.5 cm or more, or one that appears to extend beyond the prostate, which brings staging questions with it.
A 5 is awarded for size of 1.5 cm or above, or for definite extension outside the prostate, so two very different reports share the number.
In pooled data, about 69% of PI-RADS 5 lesions held clinically significant cancer on targeted biopsy, which means roughly three in ten did not.
A PI-RADS 5 report usually also comments on the gland margin, the seminal vesicles, and the nerve bundles, because those affect staging.
Choose how you want to understand this
The full explanation.
Two different findings earn the same 5
PI-RADS v2.1 defines category 5 as very high: clinically significant cancer is highly likely to be present.
Look at how the definition is written, though. In every zone of the gland, a 5 is described as the same appearance as a 4, but either 1.5 cm or larger in its longest measurement, or with definite extension outside the prostate.
That is an "or". Two men can both hold a report saying 5 and be in different situations:
- a well-contained lesion that happens to measure 1.5 cm or more
- a smaller lesion that appears to break through the edge of the gland
The number alone does not separate them. The sentence next to it does.
Why reaching outside the gland changes the conversation
Size is a matter of degree. Extension is a change of category.
When the report describes definite extraprostatic extension, the question stops being only "is there cancer" and starts including "how far". PI-RADS v2.1 shows exactly this in one of its worked examples, describing a transition zone lesion with extraprostatic extension as a putative stage T3a on MRI.
Putative is doing real work in that phrase. MRI is proposing a stage. It is not setting one.
The odds behind a 5
A meta-analysis pooled 56 studies and 16,537 men. Looking at targeted biopsies, it found clinically significant cancer in about 69% of PI-RADS 5 lesions.
That is the highest figure on the scale, and it is not 100%. Around three in ten PI-RADS 5 lesions did not hold significant cancer on targeted sampling.
The same work found targeted biopsy missed about 5% of significant cancers in PI-RADS 5 lesions, which is why systematic cores are often taken as well.
Biopsy remains the step that names the disease. PI-RADS v2.1 says biopsy should be considered for a 4 or a 5.
What else a PI-RADS 5 report is looking at
The PI-RADS v2.1 reporting template asks for more than a number. On a high-scoring study, the parts worth finding in your own report include:
- the prostate margin, recorded as no involvement, indeterminate, or definite extraprostatic extension
- the distance from the main lesion, or any PI-RADS 4 or 5 lesion, to the nerve bundles beside the gland
- the seminal vesicles
- the prostate volume, which allows PSA density to be calculated
Those lines exist because surgeons and radiation teams plan around them.
The scan proposes a stage; tissue and the team set it
PI-RADS v2.1 is strict that the category comes from the MRI alone. It should not fold in your PSA, your rectal exam, your history, or any planned treatment.
That keeps the score honest, and it also limits it. Stage is assembled afterwards from exam findings, PSA, the pathology, and sometimes further scans.
NCI notes that additional staging tests are often reserved for people with symptoms or signs suggesting spread, such as bone pain, a high PSA, or a high Gleason score. Newer PSMA PET scans are also used in higher-risk situations.
What tends to happen next
A high score usually speeds things up rather than changing their order:
- a urology appointment, often within days to a few weeks
- a targeted biopsy, commonly with systematic cores as well
- pathology giving a Gleason score and Grade Group
- a discussion of options once grade, PSA, and stage are all in hand
- sometimes further imaging before treatment is chosen
Ask what the expected timeline is at your center, and who to contact if it slips.
Questions about staging and next tests
- Was the 5 based on size, on extension, or both?
- What did the report say about the margin and the seminal vesicles?
- Is any further imaging planned before treatment is discussed?
- Which specialists will look at my case together?
- What is the plan if the biopsy grade is lower than the scan suggested?
When to seek help sooner
Do not wait for the next appointment if you cannot pass urine at all, see blood in your urine that does not settle, or develop a fever with chills after a biopsy. Contact your care team or seek urgent care.
Related reading
For the rung below, see What Does PI-RADS 4 Mean. A tour of all five categories is in What Does PI-RADS Mean. Grading is covered in What Does Grade Group Mean in Prostate Cancer and What Does a Gleason Score Mean.
Sources
Words to know
Tap any term to see what it means.
Common questions
Does PI-RADS 5 mean the cancer has spread?
Not on its own. One route to a 5 is a lesion of 1.5 cm or more that is still inside the prostate. The other is definite extension outside it. The report wording tells you which one applies.
Is a biopsy still needed after a PI-RADS 5?
Yes, for grading. PI-RADS v2.1 says biopsy should be considered for a 4 or a 5. Only tissue gives a Gleason score and Grade Group, and those drive treatment options.
How often is a PI-RADS 5 wrong?
A meta-analysis of 56 studies found about 69% of PI-RADS 5 lesions contained clinically significant cancer on targeted biopsy. That leaves roughly three in ten that did not.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-21 what this meansLast updated: 2026-08-10Next planned review: 2027-07-21
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share